Rosti V, Lembo G, Petrini C, Gorini F, Quadri R, Cordiglieri C, Mutarelli M, Salviato E, Casari E, Di Patrizio Soldateschi E, Montanari E, Albo G, Ripa F, Fasciani A, Crosti M, De Lorenzis E, Maggioni M, Vaira V, Vivo M, Ferrari F, Lanzuolo C

Chromatin remodeling restrains oncogenic functions in prostate cancer.

Nat Commun 2025; 9174. doi: 10.1038/s41467-025-64213-4

Alaimo A, Carbone FG, Buzo K, Annesi N, Genovesi S, Lorenzato A, Widmann K, Libergoli M, Marmocchi E, Bertalot G, Brolese A, Papotti MG, Molinaro L, Caffo O, Barbareschi M, Bardelli A, Romanel A, Arena S, Lunardi A

TRPM8 levels determine tumor vulnerability to channel agonists.

Mol Oncol 2025; 2905-2920. doi: 10.1002/1878-0261.70049

Vanni G, Citron A, Suli A, Contessotto P, Caire R, Gandin A, Mantovan G, Zanconato F, Brusatin G, Di Palma M, Peirano E, Pozzer LS, Albanese C, Steiner RA, Cordenonsi M, Panciera T, Piccolo S

Microtubule architecture connects AMOT stability to YAP/TAZ mechanotransduction and Hippo signalling.

Nat Cell Biol 2025; 1725-1738. doi: 10.1038/s41556-025-01773-z

Zribi S, Giannitelli GJ, Bernardini L, Censi F, Camerini S, Bertuccini L, Iosi F, Giannella E, Sanchez M, Consoli E, Casagrande A, Cenci A, Floridia G, Novelli A, Giuliani A, Costanzo V, Crescenzi M, Pajalunga D

Structural obstruction to full DNA replication in terminally differentiated skeletal muscle cells.

EMBO Rep 2025; 4633-4655. doi: 10.1038/s44319-025-00554-x

Cancila V, Bertolazzi G, Chan AS, Medico G, Bastianello G, Morello G, Paysan D, Lai C, Hong L, Shenoy G, Jaynes PW, Schiavoni G, Mattei F, Piconese S, Revuelta MV, Noto F, Businaro L, De Ninno A, Cammarata I, Pagni F, Venkatachalapathy S, Sangaletti S, Di Napoli A, Cicio G, Vacca D, Lonardi S, Lorenzi L, Ferreri AJ, Belmonte B, Liu M, Lakshmanan M, Ong MS, Zhang B, See T, Lam KP, Varano G, Colombo MP, Bicciato S, Inghirami G, Cerchietti L, Ponzoni M, Zappasodi R, Metzger E, Beechem J, Facchetti F, Foiani M, Casola S, Jeyasekharan AD, Tripodo C

Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone.

J Clin Invest 2025; . doi: 10.1172/JCI187371

Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillère R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Blériot C, Liu P, Zhao L, Creusot L, Rolhion N, Derosa L, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C

Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Cancer Discov 2025; 1905-1926. doi: 10.1158/2159-8290.CD-24-1230

Ward JC, Morgan M, Wood J, Woolley C, de Menezes AAN, Finch A, Sherwood K, Huang Q, Henry CS, Fernández-Tajes J, Soriano I, Thorn S, Legge I, McCullagh J, Kerr D, Kerr R, Hejmadi RK, Arends MJ, Domingo E, Maughan T, Bardella C, Tomlinson I

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.

J Pathol 2025; 40-55. doi: 10.1002/path.6446

Talarico G, Lecchi M, Zanichelli A, Portararo P, Botti L, Cappelletti V, Costanza M, Piva A, Pratesi P, Bertolini F, Di Nicola M, Tripodo C, Cancila V, Pupa SM, Colombo MP, Chiodoni C, Verderio P, Sangaletti S

ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs.

J Exp Clin Cancer Res 2025; 264. doi: 10.1186/s13046-025-03518-0

Vitiello PP, Valsecchi AA, Duregon E, Di Celle PF, Cassoni P, Papotti M, Bardelli A, Di Maio M

KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges.

Cancers (Basel) 2025; . doi: 10.3390/cancers17172803

Matikas A, Naume B, Wildiers H, Sonke G, Dieci MV, Karakatsanis A, Andersson A, Barnekow E, Kessler LE, Einbeigi Z, Killander F, Linderholm B, Schiza A, Valachis A, Nearchou A, Engebraaten O, Porojnicu A, Soland MH, Mannsåker B, Raj SX, Blix ES, Nordstrand CS, Lambertini M, Vernieri C, Punie K, Sotiriou C, Bergh J, Villacampa G, Zouzos A, Hellström M, Hartman J, Foukakis T

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

BMJ Open 2025; e102626. doi: 10.1136/bmjopen-2025-102626

Brunet L, Alexandre D, Lee J, Blanquer-Rosselló MDM, Bracquemond D, Guernet A, Chhouri H, Goupil M, Kherrouche Z, Arabo A, Mancini M, Cartier D, Yao S, Godefroy D, Dehedin J, Li JR, Duparc C, Jamme P, Vinchent A, Bérard C, Tulasne D, Arena S, Bardelli A, Cheng C, Cho BC, Wurtz O, Coulouarn C, Maraver A, Aaronson SA, Cortot AB, Anouar Y, Grumolato L

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Nat Commun 2025; 7853. doi: 10.1038/s41467-025-61788-w

Castagnoli L, Bonì F, Bigliardi M, Toneguzzo P, Corsetto PA, Galasso G, Franceschini A, Cocomazzi P, Regondi V, Capuzzoni C, Rizzo AM, Ligorio F, Vernieri C, Seneci P, Arosio D, Tagliabue E, Mastrangelo E, Milani M, Pupa SM

Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.

Sci Rep 2025; 28709. doi: 10.1038/s41598-025-14639-z

Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri A, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F

Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.

Breast 2025; 104502. doi: 10.1016/j.breast.2025.104502

D'Oria C, Cincinelli G, Bason R, Pisati F, Simoncello F, Scotti I, Giudice L, Suardi I, Ferrua P, Fossati C, Randelli PS, Caporali R, Pagani M, Ingegnoli F

Patient-Derived Explants of Osteoarthritic Synovium as Ex Vivo Model for Preclinical Research.

Int J Mol Sci 2025; . doi: 10.3390/ijms26146665

Vaurs M, Claude E, Zanella E, Rodrigues J, Nassour J, Karlseder J, Azzalin CM, Doksani Y, Decottignies A

TRF1 relies on fork reversal to prevent fragility at human telomeres.

Nat Commun 2025; 6439. doi: 10.1038/s41467-025-61828-5

Marasco M, Kumar D, Garcia Borrego S, Seale T, Maddalena G, Mezzadra R, Belanger K, Cole S, Perez B, Luan W, Mukherjee R, Aricescu I, Markov V, Zhu Y, Arena S, Bardelli A, de Stanchina E, Lowe SW, Burkhart RA, Zimmerman JW, Yaeger R, Kopetz SE, Rosen N, Misale S

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Cancer Discov 2025; 1392-1409. doi: 10.1158/2159-8290.CD-24-0614

Orita K, Fujibayashi S, Okuzu Y, Yamaguchi S, Goto K, Otsuki B, Kawai T, Shimizu T, Hayashi M, Ikeda N, Takaoka Y, Honda S, Ikezaki T, Matsuda S

Biocompatibility and antibacterial activity of strontium and silver ion-releasing titanium with high silver treatment concentration.

J Biomater Appl 2025; 20-35. doi: 10.1177/08853282251329276

Varano G, Lonardi S, Sindaco P, Pietrini I, Morello G, Balzarini P, Vit F, Neuman H, Bertolazzi G, Brambillasca S, Parr NC, Chiarini M, Bellesi S, Maiolo E, Giampaolo S, Mainoldi F, Selvarasa V, Arima H, Pellegrini V, Pagani C, Bugatti M, Ranise C, Taddei TM, Sonoki T, Thanasi H, Morlacchi E, Segura-Garzon D, Albertini E, Daffini R, Sivacegaram A, Yang H, Li Y, Cancila V, Cicio G, Robusto M, Leuzzi B, Andronache A, Trifiro P, Riboni M, Minardi SP, Bonnal RJP, Gonzalez CL, Visco E, Capaccio P, Torretta S, Pignataro L, Almici C, Varasi M, Larocca LM, Siebert R, Falini B, Ferreri AJM, Tucci A, Lorenzini D, Cabras AD, Pruneri G, Di Napoli A, Ungari M, Pizzi M, Hohaus S, Mercurio C, Song JY, Chan WC, Lorenzi L, Bomben R, Ponzoni M, Mehr R, Tripodo C, Facchetti F, Casola S

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

Blood Cancer Discov 2025; 364-393. doi: 10.1158/2643-3230.BCD-25-0099

Pizzi M, Lorenzi L, Scarmozzino F, Albertini E, Balzarini P, Sbaraglia M, Santoro L, Chiudinelli M, Mussolin L, Carraro E, Cutrone C, Casola S, Pellegrini V, Nalio S, Bonaldi L, Pillon M, Dei Tos AP

Reactive Bcl2-positive germinal centres in paediatric tonsils: expanding the spectrum of lymphoma mimickers in children and adolescents.

Histopathology 2025; 145-152. doi: 10.1111/his.15460

Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Miliziano D, Menichetti A, Ligorio F, Zurlo C, Griguolo G, Berton Giachetti PP, Faso V, Corti C, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.

Ann Oncol 2025; 762-774. doi: 10.1016/j.annonc.2025.03.023

Gu J, Iyer A, Wesley B, Taglialatela A, Leuzzi G, Hangai S, Decker A, Gu R, Klickstein N, Shuai Y, Jankovic K, Parker-Burns L, Jin Y, Zhang JY, Hong J, Niu X, Costa JA, Pezet MG, Chou J, Chen C', Paiva M, Snoeck HW, Landau DA, Azizi E, Chan EM, Ciccia A, Gaublomme JT

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap.

Nat Biotechnol 2025; 1101-1115. doi: 10.1038/s41587-024-02386-x

Magaton IM, Blondeaux E, Hamy AS, Linn S, Bernstein-Molho R, Peccatori FA, Ferrari A, Carrasco E, Paluch-Shimon S, Agostinetto E, Venturelli M, Luis IMV, Rodriguez-Wallberg KA, Kim HJ, Sorouri K, Renaud T, Moore HCF, Cui W, Bajpa J, Rousset-Jablonski C, De Marchis L, Yerushalmi R, Wong SM, Han S, Phillips KA, Pogoda K, Puglisi F, Chirco A, Duhoux FP, Meattini I, Villarreal-Garza C, Vernieri C, Bruzzone M, Demeestere I, Azim HA, Partridge AH, Lambertini M

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Eur J Cancer 2025; 115434. doi: 10.1016/j.ejca.2025.115434

Blondeaux E, Sonnenblick A, Agostinetto E, Bas R, Kim HJ, Franzoi MA, Bernstein-Molho R, Linn S, Kwong A, Pogoda K, Balmana J, Smeets A, Bajpai J, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Peccatori FA, Renaud T, Ferrari A, Paluch-Shimon S, Mando P, Lee JE, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Guven DC, Lee M, Villarreal-Garza C, Hwang SE, De Marchis L, Puglisi F, Kemp Z, Meireles PA, Parokonnaya A, Werutsky G, Okano M, Azim HA, Mati K, Rosenberg S, Gelber R, Boni L, Lambertini M

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

Lancet Oncol 2025; 759-770. doi: 10.1016/S1470-2045(25)00152-4

Nichetti F, Brambilla M, Duca M, Piccolo A, Miliziano D, Cavalli C, Marra F, Ambrosini P, Zanella C, Vernieri C, Lorenzini D, Colombo E, Damian S, Baili P, Proto C, Busico A, Conca E, Capone I, Manoukian S, Tamborini E, Perrone F, Niger M, Vingiani A, Agnelli L, de Braud F, Pruneri G

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

JCO Precis Oncol 2025; e2400387. doi: 10.1200/PO-24-00387

Maspero E, Cappa A, Weber J, Trifirò P, Amici R, Bruno A, Fagà G, Cecatiello V, Fattori R, Leuzzi B, Taibi V, Meroni G, Pasi M, Romussi A, Sartori L, Villa M, Vultaggio S, Cirò M, Soffientini P, Lombardo L, Dahe S, Bachi A, Varasi M, Rossi M, Pasqualato S, Mercurio C, Polo S

Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4.

Commun Chem 2025; 164. doi: 10.1038/s42004-025-01557-4

Grassi E, Vurchio V, Cresswell GD, Catalano I, Lupo B, Sassi F, Galimi F, Borgato S, Ferri M, Viviani M, Pompei S, Urgese G, Chen B, Zanella ER, Cottino F, Russo M, Mauri G, Pietrantonio F, Zampino MG, Lazzari L, Marsoni S, Bardelli A, Lagomarsino MC, Sottoriva A, Trusolino L, Bertotti A

Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.

Sci Transl Med 2025; eado1641. doi: 10.1126/scitranslmed.ado1641

De Micheli V, Agnelli L, Conca E, Rabsiun Aramburu VL, Baggi A, Vingiani A, Duca M, Perrone F, Tamborini E, Piccolo A, Lorenzini D, Busico A, Capone I, Niger M, Proto C, Vernieri C, Manoukian S, Gancitano G, Ferrario M, Franzini JM, De Braud F, Pruneri G, Jommi C

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

BMJ Open 2025; e099134. doi: 10.1136/bmjopen-2025-099134

De Placido P, Di Rienzo R, Pietroluongo E, Martinelli C, Tafuro M, Formisano P, D'Esposito V, Poggio FB, Ruelle T, Cardinali B, Di Lauro V, Buono G, Caputo R, Buonaiuto R, Caltavituro A, Rocco P, Porciello G, De Laurentiis M, Del Mastro L, Vernieri C, Veneziani BM, Bianco R, Crispo A, De Angelis C, Arpino G, Giuliano M

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Eur J Cancer 2025; 115409. doi: 10.1016/j.ejca.2025.115409

Lambertini M, Blondeaux E, Tomasello LM, Agostinetto E, Hamy AS, Kim HJ, Franzoi MA, Bernstein-Molho R, Hilbers F, Pogoda K, Wildiers H, Bajpai J, Ignatiadis M, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Criscitiello C, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Rodriguez-Wallberg KA, Duhoux FP, Livraghi L, Bruzzone M, Boni L, Balmaña J

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.

J Clin Oncol 2025; 1706-1719. doi: 10.1200/JCO-24-01334

Alcon C, Kovatcheva M, Morales-Sánchez P, López-Polo V, Torres T, Puig S, Lu A, Samitier J, Enrich C, Serrano M, Montero J

HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.

Cell Death Differ 2025; 646-656. doi: 10.1038/s41418-024-01417-z

Petti E, Di Vito S, Dinami R, Porru M, Marchesi S, Lohuis J, Zizza P, Iachettini S, Salvati E, D'Angelo C, Rizzo A, Maresca C, Ascione F, Di Benedetto A, Buglioni S, Sacconi A, Ostano P, Li Q, Stoppacciaro A, Leonetti C, van Rheenen J, Maiuri P, Scita G, Biroccio A

TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

Cell Death Dis 2025; 224. doi: 10.1038/s41419-025-07415-4

Droghetti R, Fuchs P, Iuliani I, Firmano V, Tallarico G, Calabrese L, Grilli J, Sclavi B, Ciandrini L, Cosentino Lagomarsino M

Incoherent feedback from coupled amino acids and ribosome pools generates damped oscillations in growing E. coli.

Nat Commun 2025; 3063. doi: 10.1038/s41467-025-57789-4

Peña-Gómez MJ, Rodríguez-Martín Y, Del Rio Oliva M, Wijesekara Hanthi Y, Berrada S, Freire R, Masson JY, Reyes JC, Costanzo V, Rosado IV

HMCES corrupts replication fork stability during base excision repair in homologous recombination-deficient cells.

Sci Adv 2025; eads3227. doi: 10.1126/sciadv.ads3227

Romero-Zamora D, Rogers S, Low RRJ, Page SG, Lane BJE, Kosaka S, Robinson AB, French L, Lamm N, Ishikawa F, Hayashi MT, Cesare AJ

A CPC-shelterin-BTR axis regulates mitotic telomere deprotection.

Nat Commun 2025; 2277. doi: 10.1038/s41467-025-57456-8

Bertolazzi G, Cancila V, Vacca D, Belmonte B, Lecis D, Moghaddam PS, Di Napoli A, Colombo MP, Pruneri G, Del Sal G, Scita G, Fassan M, Vecchione A, Bicciato S, Tripodo C

Extraction of a stromal metastatic gene signature in breast cancer via spatial profiling.

J Exp Clin Cancer Res 2025; 89. doi: 10.1186/s13046-025-03353-3

Marchesi S, Guidolin C, Massey AE, Lemahieu G, Lavagnino Z, Beznoussenko GV, Mironov AA, Green B, Allievi E, Martini E, Magni S, Ghisleni A, Lomazzi C, Benvenuto AF, Schertel A, Parazzoli D, Maiuri P, Sigismund S, Gauthier N, Cavalcanti-Adam AE, Cartagena-Rivera AX, Giavazzi F, Scita G, Disanza A

Biophysical and Molecular mechanisms that control active wetting and tissue fluidification in epithelial tissues.

Res Sq 2025; . doi: 10.21203/rs.3.rs-6008502/v1

Stier AB, Bonaiuti P, Juhász J, Gross F, Ciliberto A

lncreased risk of slippage upon disengagement of the mitotic checkpoint.

PLoS Comput Biol 2025; e1012879. doi: 10.1371/journal.pcbi.1012879

Walsh ZH, Shah P, Kothapalli N, Shah SB, Nikolenyi G, Brodtman DZ, Leuzzi G, Rogava M, Mu M, Ho P, Abuzaid S, Vasan N, AlQuraishi M, Milner JD, Ciccia A, Melms JC, Izar B

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens.

Nat Biotechnol 2025; 384-395. doi: 10.1038/s41587-024-02235-x

Bonilla-Quintana M, Ghisleni A, Gauthier NC, Rangamani P

Dynamic mechanisms for membrane skeleton transitions.

J Cell Sci 2025; . doi: 10.1242/jcs.263473

Di Giovannantonio M, Hartley F, Elshenawy B, Barberis A, Hudson D, Shafique HS, Allott VES, Harris DA, Lord SR, Haider S, Harris AL, Buffa FM, Harris BHL

Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures.

Cell Genom 2025; 100764. doi: 10.1016/j.xgen.2025.100764

Tamburri S, Zucchelli C, Matafora V, Zapparoli E, Jevtic Z, Farris F, Iannelli F, Musco G, Bachi A

SP140 represses specific loci by recruiting polycomb repressive complex 2 and NuRD complex.

Nucleic Acids Res 2025; . doi: 10.1093/nar/gkae1215

Ligorio F, Vingiani A, Torelli T, Sposetti C, Drufuca L, Iannelli F, Zanenga L, Depretto C, Folli S, Scaperrotta G, Capri G, Bianchi GV, Ferraris C, Martelli G, Maugeri I, Provenzano L, Nichetti F, Agnelli L, Lobefaro R, Fucà G, Fotia G, Mariani L, Morelli D, Ladisa V, De Santis MC, Lozza L, Trecate G, Belfiore A, Brich S, Bertolotti A, Lorenzini D, Ficchì A, Martinetti A, Sottotetti E, Arata A, Corsetto P, Sorrentino L, Rediti M, Salvadori G, Minucci S, Foiani M, Apolone G, Pagani M, Pruneri G, de Braud F, Vernieri C

Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients.

Cell Metab 2025; 330-344.e7. doi: 10.1016/j.cmet.2024.11.004

%PLACEHOLDER%